1. Home
  2. CLLS vs SRBK Comparison

CLLS vs SRBK Comparison

Compare CLLS & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • SRBK
  • Stock Information
  • Founded
  • CLLS 1999
  • SRBK 1887
  • Country
  • CLLS France
  • SRBK United States
  • Employees
  • CLLS N/A
  • SRBK N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • SRBK
  • Sector
  • CLLS Health Care
  • SRBK
  • Exchange
  • CLLS Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • CLLS 143.4M
  • SRBK 117.4M
  • IPO Year
  • CLLS 2007
  • SRBK N/A
  • Fundamental
  • Price
  • CLLS $1.59
  • SRBK $14.43
  • Analyst Decision
  • CLLS Buy
  • SRBK
  • Analyst Count
  • CLLS 1
  • SRBK 0
  • Target Price
  • CLLS $4.00
  • SRBK N/A
  • AVG Volume (30 Days)
  • CLLS 48.2K
  • SRBK 115.0K
  • Earning Date
  • CLLS 08-05-2025
  • SRBK 07-25-2025
  • Dividend Yield
  • CLLS N/A
  • SRBK 1.38%
  • EPS Growth
  • CLLS N/A
  • SRBK N/A
  • EPS
  • CLLS N/A
  • SRBK N/A
  • Revenue
  • CLLS $54,747,000.00
  • SRBK $27,988,000.00
  • Revenue This Year
  • CLLS $48.52
  • SRBK N/A
  • Revenue Next Year
  • CLLS $5.17
  • SRBK N/A
  • P/E Ratio
  • CLLS N/A
  • SRBK N/A
  • Revenue Growth
  • CLLS 351.26
  • SRBK 23.80
  • 52 Week Low
  • CLLS $1.10
  • SRBK $9.23
  • 52 Week High
  • CLLS $2.43
  • SRBK $14.96
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 56.98
  • SRBK 78.62
  • Support Level
  • CLLS $1.56
  • SRBK $13.46
  • Resistance Level
  • CLLS $1.49
  • SRBK $14.96
  • Average True Range (ATR)
  • CLLS 0.09
  • SRBK 0.25
  • MACD
  • CLLS 0.01
  • SRBK 0.12
  • Stochastic Oscillator
  • CLLS 80.00
  • SRBK 74.76

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: